Recent real-world data reveals that popular GLP-1 receptor agonists, including semaglutide and tirzepatide, are associated with a significant reduction in alcohol-related hospital visits. According to a study published by researchers …
Tag:
obesity
-
-
Modifiable cardiovascular risk factors directly influence the development of unstable coronary artery plaques, according to clinical research published in peer-reviewed cardiovascular literature. Managing blood pressure, cholesterol levels, and lifestyle habits …
-
The Primary Care Crisis: Why Payment Reform Is Essential for Patient Outcomes The U.S. health care system faces a persistent challenge: balancing the essential role of primary care with the …
-
In 2023, nearly 6,700 individuals accessed support services through Bodywhys, the national voluntary organization for people affected by eating disorders in Ireland. This figure represents a sustained demand for mental …
-
Researchers have identified a potential therapeutic strategy for acute myeloid leukemia (AML) by combining metabolic intervention with anti-inflammatory treatment. A study published in Nature Cancer demonstrates that targeting the specific …
-
Gut Microbiota May Influence Eating Behavior, Paving the Way for New Obesity Treatments Recent research suggests that gut microbiota could play a significant role in shaping eating behaviors, potentially leading …
-
Researchers have identified a small molecule compound that may inhibit the growth of pancreatic ductal adenocarcinoma (PDAC), according to a study published in the journal Scientific Reports. The compound targets …
-
A secret shopper study published in the Journal of the American Medical Association found that nearly 50 direct-to-consumer telehealth sites prescribe GLP-1 medications for weight loss. The research, conducted by …
-
Medication Masks Obesity’s Metabolic Toll The long-standing gap in cardiovascular risk markers between adults with obesity and those with a normal Body Mass Index (BMI) has significantly narrowed. A study …
-
Obesity contributes to as many as one in four cases of polypharmacy—the concurrent use of multiple medications—according to recent findings published in the journal PLOS ONE. Researchers identified a direct …
Newer Posts